As of Jun 14
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Sierra Oncology Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a +960.61% increase from the last price of 0.66.
The current consensus among 3 polled investment analysts is to Buy stock in Sierra Oncology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.